Literature DB >> 1452074

Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel.

J M Nightingale1, J E Lennard-Jones, D J Gertner, S R Wood, C I Bartram.   

Abstract

Forty six patients with less than 200 cm of normal jejunum and no functioning colon were compared with 38 patients with similar jejunal lengths in continuity with a functioning colon. Women predominated (67%), and the most common diagnosis in each group was Crohn's disease (33 of 46 no colon, 16 of 38 with colon). All patients without a colon and less than 85 cm of jejunum and all those with a colon and less than 45 cm jejunum needed long term parenteral nutrition. Six months after the last resection 12 of 17 patients with less than 100 cm jejunum and no colon needed intravenous supplements compared with 7 of 21 with a colon. Between 6 months and 2 years, little change occurred in the nutritional/fluid requirements in either group, though there was weight gain. Of 71 patients assessed clinically at a median of 5 years, none with more than 50 cm of jejunum and a colon needed parenteral supplements. Most (25 of 27) of those without a colon who did not need parenteral supplements required oral electrolyte replacement compared with few (4 of 27) with a colon. None of the patients without a colon developed symptomatic renal stones compared with 9 of 38 (24%) with a colon (p < 0.001). Stone analysis in three patients showed calcium oxalate. Gall stone prevalence was high but equal in the two groups--43% of those without and 44% of those with a colon.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1452074      PMCID: PMC1379534          DOI: 10.1136/gut.33.11.1493

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  41 in total

1.  Loss of the entire jejunum and ileum, and the ascending colon. Management of a patient.

Authors:  J M KINNEY; R M GOLDWYN; J S BARR; F D MOORE
Journal:  JAMA       Date:  1962-02-17       Impact factor: 56.272

2.  Massive resection of the small intestine.

Authors:  J R MARTIN; C J PATTEE; C GARDNER; B MARIEN
Journal:  Can Med Assoc J       Date:  1953-10       Impact factor: 8.262

Review 3.  Epidemiology and natural history of gallstone disease.

Authors:  C Sama; A M Labate; F Taroni; L Barbara
Journal:  Semin Liver Dis       Date:  1990-08       Impact factor: 6.115

4.  Small bowel length in Crohn's disease.

Authors:  G Slater; A H Aufses
Journal:  Am J Gastroenterol       Date:  1991-08       Impact factor: 10.864

5.  Length of residual small bowel after partial resection: correlation between radiographic and surgical measurements.

Authors:  J M Nightingale; C I Bartram; J E Lennard-Jones
Journal:  Gastrointest Radiol       Date:  1991

6.  Total parenteral nutrition needs in different types of short bowel syndrome.

Authors:  M C Gouttebel; B Saint-Aubert; C Astre; H Joyeux
Journal:  Dig Dis Sci       Date:  1986-07       Impact factor: 3.199

7.  Capacity of the human colon to absorb fluid.

Authors:  J C Debongnie; S F Phillips
Journal:  Gastroenterology       Date:  1978-04       Impact factor: 22.682

8.  Effect of bile salts and fatty acids on the colonic absorption of oxalate.

Authors:  J W Dobbins; H J Binder
Journal:  Gastroenterology       Date:  1976-06       Impact factor: 22.682

9.  Fat-reduced diet in the treatment of hyperoxaluria in patients with ileopathy.

Authors:  H Andersson; R Jagenburg
Journal:  Gut       Date:  1974-05       Impact factor: 23.059

10.  Importance of the colon in enteric hyperoxaluria.

Authors:  J W Dobbins; H J Binder
Journal:  N Engl J Med       Date:  1977-02-10       Impact factor: 91.245

View more
  40 in total

1.  Differential protein expression during colonic adaptation in ultra-short bowel rats.

Authors:  Hai-Ping Jiang; Tao Chen; Guang-Rong Yan; Dan Chen
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 2.  The use of hormonal growth factors in the treatment of patients with short-bowel syndrome.

Authors:  Palle B Jeppesen
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Enhancing bowel adaptation in short bowel syndrome.

Authors:  Palle Bekker Jeppesen; Per Brobech Mortensen
Journal:  Curr Gastroenterol Rep       Date:  2002-08

Review 4.  The medical and surgical management of short bowel syndrome.

Authors:  Alan L Buchman
Journal:  MedGenMed       Date:  2004-05-13

5.  Guidelines for management of patients with a short bowel.

Authors:  J Nightingale; J M Woodward
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

6.  Development of a bioartificial new intestinal segment using an acellular matrix scaffold.

Authors:  Mohan P Pahari; Melissa L Brown; Georg Elias; Hannan Nseir; Barbara Banner; Cristiana Rastellini; Luca Cicalese
Journal:  Gut       Date:  2007-06       Impact factor: 23.059

7.  Changes induced in colonocytes by extensive intestinal resection in rats.

Authors:  Hubert Lardy; Muriel Thomas; Marie-Louise Noordine; Aurélia Bruneau; Claire Cherbuy; Pierre Vaugelade; Catherine Philippe; Virginie Colomb; Pierre-Henri Duee
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

8.  Reconnection surgery in adult post-operative short bowel syndrome < 100 cm: is colonic continuity sufficient to achieve enteral autonomy without autologous gastrointestinal reconstruction? Report from a single center and systematic review of literature.

Authors:  A Lauro; R Cirocchi; N Cautero; A Dazzi; D Pironi; F M Di Matteo; A Santoro; L Pironi; A D Pinna
Journal:  G Chir       Date:  2017 Jul-Aug

9.  Ghrelin does not predict adaptive hyperphagia in patients with short bowel syndrome.

Authors:  Charlene W Compher; Bruce P Kinosian; David C Metz
Journal:  JPEN J Parenter Enteral Nutr       Date:  2009-01-27       Impact factor: 4.016

Review 10.  Intestinal adaptation after massive intestinal resection.

Authors:  A R Weale; A G Edwards; M Bailey; P A Lear
Journal:  Postgrad Med J       Date:  2005-03       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.